Does transitioning from the Pooled Cohort Equations to the AHA PREVENT model disproportionately affect statin eligibility for non-Hispanic Black adults?
Transitioning to the AHA PREVENT equations for cardiovascular risk assessment may disproportionately alter statin eligibility for non-Hispanic Black adults, highlighting the need for disparity-focused monitoring.
Transitioning from PCE to PREVENT recalibrates statin eligibility and may disproportionately affect non-Hispanic Black adults. Disparity-focused monitoring is essential for clinical implementation of this new model.
Yan et al. (Sun,) studied this question.